ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Geriatric Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,251Medicare Part D Prescriptions Filled, Including Refills

Rank: 7 out of 15

$512K Total Retail Price of All Prescriptions

Rank: 5 out of 15

348 Patients Receiving at Least One Drug in Part D
84%Patients 65 Years and Older
67% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Maine
Lower avg

Schedule Two
Controlled Substances

14% of this provider’s 348 patients filled at least one prescription for a schedule two drug, compared to an average of 11%.

Schedule Three
Controlled Substances

11% of this provider’s 348 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

3% of this provider’s 5,426 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$71 was the average price of a prescription from this provider, compared to $57 among peers.

Prescriptions per Patient

21 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Maine
LEVOTHYROXINE SODIUM 261 212 1 5
LISINOPRIL 245 206 2 2
METOPROLOL TARTRATE 229 192 3 3
FUROSEMIDE 204 169 4 4
OMEPRAZOLE 197 149 5 7
METFORMIN HCL 177 144 6 11
HYDROCHLOROTHIAZIDE 171 153 7 9
AMLODIPINE BESYLATE 163 159 8 8
PRAVASTATIN SODIUM 156 135 9 24
OXYCODONE HCL 156 30 S2 9 28
ATENOLOL 142 105 11 20
HYDROCODONE-ACETAMINOPHEN 142 118 S3 11 12
RANITIDINE HCL 134 94 13 36
ATORVASTATIN CALCIUM 131 117 14 13
WARFARIN SODIUM 112 103 15 6
SIMVASTATIN 109 106 16 1
TRAZODONE HCL 106 52 17 16
GLYBURIDE 105 105 R 18 44
METOPROLOL SUCCINATE 101 100 19 14
MIRTAZAPINE 94 67 20 29
AMITRIPTYLINE HCL 82 24 R 21 81
ADVAIR DISKUS 80 66 22 22
CITALOPRAM HBR 71 61 23 17
GABAPENTIN 66 42 24 15
PROMETHAZINE HCL 66 24 R 24 92
PANTOPRAZOLE SODIUM 66 48 24 27
DIGOXIN 62 45 27 49
ZOLPIDEM TARTRATE 58 40 28 34
BUPROPION XL 58 17 28 105
VENTOLIN HFA 56 29 30 110
LOVASTATIN 55 54 31 43
ALLOPURINOL 54 46 32 46
ENALAPRIL MALEATE 54 53 32 59
ISOSORBIDE MONONITRATE ER 53 38 34 30
CRESTOR 51 34 35 48
OXYBUTYNIN CHLORIDE 50 31 36 126
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 28, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.